ArielMarciscanoMD

Radiation Oncology • Boston, MA

Central Nervous System Cancer

Assistant Professor of Radiation Oncology, Harvard Medical School Radiation Oncology Service at Massachusetts General Hospital

Join to view full profile

Dr. Marciscano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Marciscano's full profile

Already have an account?

Office
55 Fruit St
Boston, MA 02114
Is this information wrong?

Education & Training

National Cancer InstituteImmunotherapy, 2017 - 2018
Johns Hopkins University School of MedicineRadiation Oncology, 2013 - 2017
Massachusetts General HospitalInternal Medicine, 2012 - 2013
New York University School of MedicineClass of 2012

Certifications & Licensure

FL State Medical License 2022 - Present
MA State Medical License 2023 - 2025
ME State Medical License 2023 - 2025
NH State Medical License 2023 - 2025
NY State Medical License 2018 - 2025
NJ State Medical License 2018 - 2025
RI State Medical License 2023 - 2024
MD State Medical License 2017 - 2021
American Board of Radiology Radiation Oncology
Join now to see all

Publications & Presentations

PubMed

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).
Sydney Wolfe, Marshall A Diven, Ariel E Marciscano, Xi Kathy Zhou, A U Kishan, M L Steinberg, Joseph A Miccio, Philip Camilleri, Himanshu Nagar> ;BMC Cancer. 2023 Sep 30
2 citations
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).
Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, Christopher E Barbieri, Silvia C Formenti, Jim C Hu, Ana M Molina, David M Nanus, Jones T Nauseef, Douglas S Scherr, C...> ;BMC Cancer. 2023 Aug 22
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6annual ImmunoRad conference.
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin Harrington, Fern...> ;Oncoimmunology. 2023 Jan 1

Hospital Affiliations

Massachusetts General HospitalBoston, Massachusetts